Crossmark

Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children

Published Online: 2021-09-04

Published Print: 2021-12

Authors

Li, Mengyao

Chen, Ying

Li, Huihan

Yang, Dehua

Zhou, Yunlian

Chen, Zhimin

Zhang, Yuanyuan
Funding

Funding for this research was provided by:

National Natural Science Foundation (81871264, 81871264, 81871264, 81871264, 81871264, 81871264, 81871264)
License Information

Text and Data Mining valid from 2021-09-04

Version of Record valid from 2021-09-04
More Information

Article History

Received: 15 March 2021

Accepted: 25 August 2021

First Online: 4 September 2021

Declarations

:

: This study received ethical clearance from the Ethics Committee at Children’s Hospital, Zhejiang University School of Medicine. Parents or legal guardians of all the participants provided written informed consents.

: Not applicable.

: The authors declare no competing interests.

Document is current